RxDoctor Payments Data

Catherine Beecher

Obstetrics · East Setauket, NYNPI 1164841151

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $516, more than ten times the $22 reported in 2020.

$1,517in general payments, 2019–2025

Across 71 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Evofem Biosciences, Inc.$288
  • Alydia Health$160
  • Sumitomo Pharma America, Inc.$148
  • AbbVie$132
  • Exeltis, USA Inc.$105
  • Organon$93
  • plus $592 from 9 others

What the payments were for

  • Food & beverage$1,517100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,517 in reported general payments places this provider in the 85th percentile of 82 obstetrics providers in New York.

See all obstetrics providers in New York

Medicare billing

Part B allowed, 2024
$48,546
Medicare patients
422
Services billed
909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol156$23,640
YuvafemEstradiol52$11,158
PremarinEstrogens, Conjugated17$7,528
Clobetasol Propionate20$1,460
Ibandronate Sodium16$594
ValacyclovirValacyclovir Hcl20$429
Nystatin15$168
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$124

Paid to pharmacies, not to this prescriber.

Other obstetrics in East Setauket

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →